Exploration of severe Covid-19 associated risk factor in China : Meta-analysis of current evidence

© 2021 John Wiley & Sons Ltd..

AIM: This meta-analysis aimed to explore potential risk factors for severe Covid-19.

METHODS: We systemically and comprehensively retrieved the eligible study evaluating clinical differences between severe vs non-severe Covid-19. Main effect sizes were demographic characteristics, comorbidities, signs and symptoms, laboratory findings as well as radiological features of chest CT.

RESULTS: A total of 2566 Covid-19 people (771 in the severe group and 1795 in the non-severe group) from 14 studies were eligible for this meta-analysis. It was demonstrated that older age and males were more likely to have severe Covid-19. Patients with underlying comorbidities, such as hypertension, diabetes, heart disease and COPD were significantly more susceptible to severe Covid-19. Patients with dyspnoea were more likely to be severely ill. Depressed total lymphocytes were observed in this article. Meanwhile, although reticulation (30.8%), intrathoracic lymph node enlargement (20.5%) and pleural effusions (30.8%) were relatively infrequent, meta-analysis revealed that patients with these presentations in chest CT were associated with increased risk of severe Covid-19.

CONCLUSIONS: There are significant differences in clinical characteristics between the severe and non-severe Covid-19 patients. Many factors are related to the severity of the disease, which can help clinicians to differentiate severe patients from non-severe patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:75

Enthalten in:

International journal of clinical practice - 75(2021), 12 vom: 25. Dez., Seite e14900

Sprache:

Englisch

Beteiligte Personen:

Zhang, Yun-Jing [VerfasserIn]
Sun, Xi-Feng [VerfasserIn]
Xie, Bing [VerfasserIn]
Feng, Wen-Juan [VerfasserIn]
Han, Shi-Liang [VerfasserIn]

Links:

Volltext

Themen:

Meta-Analysis

Anmerkungen:

Date Completed 31.12.2021

Date Revised 05.10.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/ijcp.14900

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM330884492